This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Asako Ishibashi: Innovator in Pharmaceutical Chemistry
Introduction: Asako Ishibashi is a prominent inventor based in Chita, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on addressing various gastrointestinal and neurological disorders through innovative chemical solutions.
Latest Patents: Asako Ishibashi holds a patent for indazole derivatives, which are compounds designed to treat conditions mediated by 5-HT agonistic activity. This invention includes a range of applications for treating gastroesophageal reflux disease, gastrointestinal diseases, and various neurological disorders. The patent encompasses compounds of the formula (I) and their pharmaceutically acceptable salts, highlighting their potential in therapeutic compositions.
Career Highlights: Throughout her career, Asako has demonstrated a commitment to advancing medical science through her research and inventions. Her work at Pfizer Corporation has positioned her as a key player in the pharmaceutical industry, where she continues to innovate and contribute to the development of effective treatments.
Collaborations: Asako collaborates with esteemed colleagues, including Tomoki Kato and Kiyoshi Kawamura. These partnerships enhance her research efforts and foster a collaborative environment for innovation in pharmaceutical development.
Conclusion: Asako Ishibashi's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing complex medical challenges. Her dedication to research and collaboration continues to drive advancements in the field, making her a notable figure in the world of inventions and patents.